Cargando…
Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
Duchenne muscular dystrophy (DMD) is an X-linked muscle-wasting disease caused by mutations in the dystrophin gene. DMD boys are wheelchair-bound around 12 years and generally survive into their twenties. There is currently no effective treatment except palliative care, although personalized treatme...
Autores principales: | Kennedy, Tahnee L., Guiraud, Simon, Edwards, Ben, Squire, Sarah, Moir, Lee, Babbs, Arran, Odom, Guy, Golebiowski, Diane, Schneider, Joel, Chamberlain, Jeffrey S., Davies, Kay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216100/ https://www.ncbi.nlm.nih.gov/pubmed/30417024 http://dx.doi.org/10.1016/j.omtm.2018.10.005 |
Ejemplares similares
-
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
por: Kennedy, Tahnee L., et al.
Publicado: (2017) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
por: Guiraud, Simon, et al.
Publicado: (2019) -
Identification of serum protein biomarkers for utrophin based DMD therapy
por: Guiraud, Simon, et al.
Publicado: (2017) -
Muscle Structure Influences Utrophin Expression in mdx Mice
por: Banks, Glen B., et al.
Publicado: (2014)